No Detail Found!

Sulforaphane ameliorated oxidative stress, inflammatory release and obesity hormones abnormalities induced by high fructose and or high fat diet in rats

Author(s)
Taha A. Kumosani Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia; Experimental Biochemistry Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; Production of Bio-products for Industrial Application Research Group, King Abdulaziz University Jeddah, Saudi Arabia
Elie K. Barbour Experimental Biochemistry Unit, King Fahd Medical Research Center, King Abdulaziz University,Jeddah,Saudi Arabia
Soonham S. Yaghmoor Experimental Biochemistry Unit, King Fahd Medical Research Center, King Abdulaziz University,Jeddah,Saudi Arabia
Said S. Moselhy Biochemistry Department, Faculty of Science, Ain Shams University,Cairo,Egypt
Abstract
The undesired complications and side effects of drugs used in obesity management is the main challenge worldwide. For that, complementary or alternative therapy depending on natural source for obesity management is the target of nutritionist for its safety. The rational of this study to investigate the role of sulforaphane (SR) in amelioration biochemical markers related to oxidative stress, inflammation and obesity hormones high fructose and or high fat diet fed rats. Eight groups of male rats (6 rats/group). Group 1: Rats fed normal diet. GP II: normal rats given SR (10 mg/kg bw). Animals in groups (III-V) were fed either high fructose (HF) or high fat (HFA) or (HF/HFA) diet. However, rats in Groups (VI-VIII): are similar to previous groups but treated orally 10 mg/kg bw SR. Data obtained showed that, SR protected from hepatic abnormalities by normalizing ALT and AST levels. A significant improvement in insulin sensitivity, restoring changes in lipid profile (TC, TG, LDL-c and HDL-c), anti-inflammatory by reducing levels of IL-6 and TNF-a, antioxidant and keeps obesity hormones from alterations compared with untreated rats. Conclusion: supplementation of SR ameliorated biochemical abnormalities induced by HF and or HFA and related hormonal, oxidative stress and inflammations. For that, it is promising to be used in the treatment of obesity-related metabolic syndrome.
Publication Details
Page(s) 1-10
Published Journal: Asian Journal of Agriculture and Biology, Volume: 2, Issue: 0, Year: 2026

Request the full text from PASTIC

Keywords
Obesity, Ghrelin, Sulforaphane, Leptin, Rats, Adiponectin, Leptin, High fructose/ high fat
References
Achari AE,Jain SK .2017 .Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int. J. Mol. Sci, 18(1321) : 1-17.
Bastard JP,Maachi M,Lagathu C,Kim MJ,Caron M,Vidal H,Capeau J,Feve B .2006 .Recent Advances in the Relationship between Obesity, Inflammation, and Insulin Resistance. Eur. Cytokine Netw, 17 : 4-12.
Berger S,Ceccarini G,Scabia G,Barone I,Pelosini C,Ferrari F,Magno S,Dattilo A,Chiovato L,Vitti P,Santini F,Maffei M .2017 .Lipodystrophy and obesity are associated with decreased number of T cells with regulatory function and pro-inflammatory macrophage phenotype. Int. J. Obes, 41 : 1676-1684.
de Souza CG,Sattler JA,de Assis AM,Rech A,Perry ML,Souza DO .2012 .Metabolic effects of sulforaphane oral treatment in streptozotocindiabetic rats. J. Med, 15(9) : 795-801.
Faggioni R,Moser A,Feingold KR,Grunfeld C .2000 .Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am. J. Pathol, 156 : 1781-1787.
Feng H,Zheng L,Feng Z,Zhao Y,Zhang N .2013 .The role of leptin in obesity and the potential for leptin replacement therapy. Endocrine, 44 : 33-39.
Folbergrová J,Ješina P,Otáhal J .2023 .Protective Effect of Sulforaphane on Oxidative Stress and Mitochondrial Dysfunction Associated with Status Epilepticus in Immature Rats. Mol. Neurobiol, 60 : 2024-2035.
Guan Z,Zhou L,Zhang Y,Chen H,Shao F .2021 .Sulforaphane ameliorates the liver injury of traumatic hemorrhagic shock rats. J. Surg. Res, 267 : 293-301.
Guilherme A,Henriques F,Bedard AH,Czech MP .2019 .Molecular pathways linking adipose innervation to insulin action in obesity and diabetes mellitus. Nat. Rev. Endocrinol, 15 : 207-225.
Hamann A,Matthaei S .1996 .Regulation of energy balance by leptin. Exp. Clin. Endocrinol Diabetes, 104(4) : 293-300.
Haslam DW,James WP .2005 .. , 366(9492) : 1197-209.
Hua D,Luo A.,Huang WZ,Li C,Xu SX,Liu C .2022 .Sulforaphane improves cognitive dysfunction after surgery and anesthesia in mice: the role of Keap1-Nrf2 signaling. Brain Research Bulletin, 181(1) : 1-11.
Ioannides-Demos LL,Proietto J,McNeil JJ .2005 .Pharmacotherapy for obesity. Drugs, 65(10) : 1391-1418.
Inui A,Asakawa A,Bowers CY,Mantovani G,Laviano A,Meguid MM,Fujimiya M .2004 .gastric motility: The emerging role of the stomach as an endocrine organ. FASEB J, 18 : 439-456.
Kaynar H,Meral M,Turhan H,Keles M,Celik G,Akcay F .2005 .Glutathione peroxidase, glutathione s-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Lett, 227 : 133-139.
Liu YL,Fu XZ,Chen ZY,Luo TT,Zhu CX,Ji YT,Bian Z .2021 .The Protective Effects of Sulforaphane on High-Fat Diet-Induced Obesity in Mice Through Browning of White Fat. Front. Pharmacol, 12 : 665894.
Luo J,Alkhalidy H,Jia Z,Liu D .2024 .Sulforaphane Ameliorates High-Fat-DietInduced Metabolic Abnormalities in Young and Middle-. Aged Obese Male Mice Foods, 13(1055) : 1-14.
Mirmiran P,Sherafat-Kazemzadeh R,Jalali-Farahani S and Azizi F .2010 .Childhood obesity in the Middle East: a review. East Mediterr. Health J, 16(9) : 1009-1017.
Mitrou P,Lambadiari V,Maratou E,Boutati E,Komesidou V,Papakonstantinou A,Raptis SA,Dimitriadis G .2011 .Skeletal muscle insulin resistance in morbid obesity: The role of inter- leukin-6 and leptin. Exp. Clin. Endocrinol Diabetes, 119 : 484-489.
Morgen CS,Sorensen TI .2014 .Global trends in the prevalence of overweight and obesity. Nat. Rev. Endocrinol, 10(9) : 513-514.
Munzberg H,Myers MG H .2005 .Molecular and anatomical deter minants of central leptin resistance. Nat. Neurosci., 8 : 566-570.
Nigro E,Scudiero O,Monaco ML,Palmieri A,Mazzarella G,Costagliola C,Bianco A,Daniele A .2014 .New insight into adipo nectin role in obesity and obesity-related diseases. Biomed. Res. Int., 658913, : .
Noble RMN,Jahandideh F,Armstrong EA,Bourque SL,Yager JY .2022 .Broccoli Sprouts Promote Sex-Dependent Cardiometabolic Health and Longevity in Long-Evans Rats. Int. J. Environ. Res. Public Health, 19 : 13468.
Ntzouvani A,Fragopoulou E,Panagiotakos D,Pitsavos C,Antonopoulou S .2016 .Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: A cross-sectional study. Lipids Health Dis, 15 : 1-14.
Okulicz M and Hertig I .2016 .Acute sulforaphane action exhibits hormonal and metabolic activities in the rat: in vivo and in vitro studies. Czech J. Anim. Sci, 61(1) : 22-31.
Pogodzi´nski D,Ostrowska L,Smarkusz-Zarzecka J,Zy´sk B .2022 .Secretome of Adipose Tissue as the Key to Understanding the Endocrine Function of Adipose Tissue. Int. J. Mol. Sci, 23 : 2309.
Santiago-Fernández C,García-Serrano S,Tome M,Valdes S,Ocana-Wilhelmi L,Rodríguez-Canete A,Tinahones FJ,García-Fuentes E,Garrido-Sánchez L .2017 .Ghrelin levels could be involved in the improvement of insulin resistance after bariatric surgery. Endocrinol. Diabetes Nut, 64 : 355-362.
Shoenberg MH,Beger HG .1993 .Reperfusion injury after intesti nal ischemia. Crit. Care Med, 21 : 1376-86.
Sjostrom L,Rissanen A,Andersen T .1998 .Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet, 352 : 167-173.
Silva V,Sousa-Filho CPB,França CD,Otton R .2024 .Controversial anti-obesity actions of epicatechin in male and female mice kept at thermoneutrality. Int. J. Mol. Sci, 1 : 17.
Sethi P,Thillai M,Nain PS,Ahuja A,Aulakh N,Khurana P .2018 .Role of hunger hormone 'Ghrelin' in long-term weight loss following laparoscopic sleeve gastrectomy. Niger J. Surg, 24 : 121-124.
Shah RE,Gayat JL,Januzzi Jr,Sato N,Cohen-Solal A,diSomma S .2014 .Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J. Am. Coll. Cardiol, 63(8) : 778-785.
Song L,Srilakshmi M,Wu Y,Saleem TS .2020 .Sul foraphane attenuates isoproterenolinduced myocardial injury in mice. , : .
Song MY,Kim EK,Moon WS,Park JW,Kim HJ,So HS,Park R,Kwon KB,Park BH .2009 ."Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-kappaB pathway. " Toxicol. Appl. Pharmacol, 235(1) : 57-67.
Thounaojam MC,Nammi S,Jadeja R .2013 .Natural products for the treatment of obesity, metabolic syndrome, and type 2 diabetes. Evid. Based Complement Alternat. Med, 871018 : 1-2.
Torres-Fuentes CH,Schellekens TG,Cryan JF .2014 ."A natural solution for obesity: Bioactives for the prevention and treatment of weight gain. A review." Nutr, : .
Uddin MS,Al Mamun A,Jakaria M,Thangapandiyan S,Ahmad J,Rahman MA,Aleya L .2020 .Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders. Science of the Total Environment, 707 : 135624.
Wu YK,Ren ZN,Zhu SL,Wu YZ,Wang G,Zhang H,Chen W,He Z,Ye XL,Zhai QX .2022 .Sulforaphane Ameliorates Non-Alcoholic Fatty Liver Disease in Mice by Promoting FGF21/FGFR1 Signaling Pathway. Acta Pharmacol. Sin, 43 : 1473-1483.
Xu Y,Fu JF,Chen JH,Zhang ZW,Zou ZQ,Han LY,Hu QH,Zhao JS,Zhang XH,Sha YJ .2018 .Sulforaphane Ameliorates Glucose Intolerance in Obese Mice via the Upregulation of the Insulin Signaling Pathway. Food Funct, 9 : 4695-4701.
Yoshitomi R,Yamamoto M,Kumazoe M,Fujimura Y,Yonekura M,Shimamoto Y,Nakasone A,Kondo S,Hattori H,Haseda A,Nishihira J,Tachibana H .2021 .The combined effect of green tea and glucosyl hesperidin in preventing obesity: A randomized placebocontrolled clinical trial. Sci. Rep, 11 : 19067.
0

Citations

0

Downloads

25

Views